<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Due to our increasing knowledge on the pathophysiological basis of <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> and the development of combined medical-obstetric clinics, pregnancy is becoming common among women with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>However, whether <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> worsens during pregnancy continues to be a controversial issue </plain></SENT>
<SENT sid="2" pm="."><plain>SLE assessment during pregnancy is sometimes difficult due to physiological changes during this period, and common tools for measuring <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> activity during pregnancy were not available until recently </plain></SENT>
<SENT sid="3" pm="."><plain>Several <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> activity scales in common use have been adapted for pregnancy [<z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> in pregnancy activity index (SLEPDAI), modified <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> activity measurement (m-SLAM) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> activity index in pregnancy (LAI-P)] </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of them take into account the influence of pregnancy on clinical manifestation and common biochemical tests </plain></SENT>
<SENT sid="5" pm="."><plain>LAI-P also accounts for specific manifestations of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in order not to score them as due to SLE activity </plain></SENT>
<SENT sid="6" pm="."><plain>LAI-P has recently been validated for use in SLE pregnancy and could be used in future studies </plain></SENT>
<SENT sid="7" pm="."><plain>However, daily assessment and management of individual pregnant women with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> still relies on the clinical skills of attending physicians </plain></SENT>
</text></document>